RxDoctor Payments Data

Raymond Weiss, MD

Otolaryngology · Ocean Springs, MSNPI 1598715393

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $217,009 of the $258,048 with a category attached, or 84.1%. Acclarent, Inc accounts for 62.4% of it on its own, with 29 other manufacturers making up the rest. Reporting peaked in 2019 at $85,819 and has fallen 97.0% since, to $2,535 in 2025. Among otolaryngology clinicians in MS with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$258,048in general payments, 2019–2025

Across 504 payments — averaging $512.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Acclarent, Inc$161K
  • Medical Device Business Services, Inc.$64K
  • Integra Lifesciences Corporation$17K
  • Smith+Nephew$12K
  • Regeneron Healthcare Solutions, Inc.$1K
  • Sanofi$642
  • plus $3K from 24 others

What the payments were for

  • Consulting fees$217,00984%
  • Travel & lodging$30,12612%
  • Food & beverage$10,8064%
  • Education$1000%
  • Gifts$70%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$258,048 in reported general payments places this provider in the 95th percentile of 97 otolaryngology providers in Mississippi.

See all otolaryngology providers in Mississippi

Medicare billing

Part B allowed, 2024
$56,097
Medicare patients
464
Services billed
1,032

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ipratropium Bromide82$2,673
Fluticasone Propionate125$1,886
Betamethasone Valerate15$180
Omeprazole18$174

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Ocean Springs

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →